Active Ingredient(s):Asenapine FDA Approved: * October 11, 2019 Pharm Company: *HISAMITSU Category:Antipsychotic
Asenapine, sold under the brand name Saphris among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania associated with bipolar disorder.
It was chemically derived via altering the chemical structure of the tetracyclic (atypical) antidepressant, mianserin.
It was approved as a generic medication in the United States in 2020.
1 Medical uses
1.2 Acute mania
2 Adverse e...
* May have multiple approval dates, manufacturers, or labelers.